Publisher: Karger
E-ISSN: 1423-002x|57|4|191-195
ISSN: 0378-7346
Source: Gynecologic and Obstetric Investigation, Vol.57, Iss.4, 2004-05, pp. : 191-195
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The aim of the present study was to evaluate the effects of intranasal estradiol on lipid metabolism and lipoprotein(a) [Lp(a)] levels. A prospective comparative study was designed: 49 hysterectomized, healthy postmenopausal women received intranasal 17β-estradiol (E2; 300 µg/day). Blood samples were collected at baseline and at the end of the 3 and 6 months of therapy. After 6 months, the serum levels of total cholesterol, LDL-cholesterol and triglycerides did not show any significant change with intranasal 17β-E2 therapy. HDL-cholesterol levels at 3 and 6 months of treatment were significantly increased compared with baseline levels (p = 0.031, p = 0.000, respectively). There was a significant change in serum Lp(a) levels at the 6th month (p = 0.003) but not at the 3rd month (p = 0.183) compared with the baseline levels. Further studies are needed to detect whether these changes are significant and permanent or not.
Related content
Half-Life of Estradiol in Postmenopausal Women
Gynecologic and Obstetric Investigation, Vol. 45, Iss. 1, 1998-01 ,pp. :
Estradiol and Weight Are Covariates of Paracetamol Clearance in Young Women
Gynecologic and Obstetric Investigation, Vol. 77, Iss. 4, 2014-03 ,pp. :